For many specialty medications, patient access challenges begin before the prescription is ever filled. That’s because prescriptions are often written without visibility into benefit design, prior authorization requirements, or optimal routing. This introduces friction at the earliest point in the access journey.

When 27% of specialty prescriptions go unfilled due to payer rejections and patient drop-off,* addressing these upstream gaps becomes critical to improving access and accelerating time to therapy.

Hear a candid conversation with two chief medical officers on what’s happening at the point of prescribing. Discover how more connected, insight-driven workflows can help reduce avoidable barriers and improve downstream outcomes for patients.

What You’ll Learn:

• Why specialty prescriptions fail before access and patient support strategies can take effect
• How misalignment between prescribing, coverage, and fulfillment introduces avoidable friction
• How in-workflow support can improve prescription accuracy, speed time to therapy, and reduce abandonment
• Why leading organizations are rethinking access as an end-to-end journey that begins at prescribing

*U.S. Medicine use Trends 2026. IQVIA. https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/understanding-the-use-of-medicines-in-the-us-2025.